250 related articles for article (PubMed ID: 32152404)
1. Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis.
Francart ME; Vanwynsberghe AM; Lambert J; Bourcy M; Genna A; Ancel J; Perez-Boza J; Noël A; Birembaut P; Struman I; Polette M; Gilles C
Oncogene; 2020 Apr; 39(18):3680-3692. PubMed ID: 32152404
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.
Fite K; Gomez-Cambronero J
J Biol Chem; 2016 Jan; 291(2):719-30. PubMed ID: 26567912
[TBL] [Abstract][Full Text] [Related]
3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
4. Tissue Factor Induced by Epithelial-Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells.
Bourcy M; Suarez-Carmona M; Lambert J; Francart ME; Schroeder H; Delierneux C; Skrypek N; Thompson EW; Jérusalem G; Berx G; Thiry M; Blacher S; Hollier BG; Noël A; Oury C; Polette M; Gilles C
Cancer Res; 2016 Jul; 76(14):4270-82. PubMed ID: 27221703
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
[TBL] [Abstract][Full Text] [Related]
6. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Tissue Factor by CD44 Supports Coagulant Activity in Breast Tumor Cells.
Villard AV; Genna A; Lambert J; Volpert M; Noël A; Hollier B; Polette M; Vanwynsberghe AM; Gilles C
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805061
[TBL] [Abstract][Full Text] [Related]
8. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
10. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
[TBL] [Abstract][Full Text] [Related]
11. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.
Das S; De S; Sengupta S
Mol Biol Rep; 2021 Mar; 48(3):2315-2324. PubMed ID: 33788053
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells.
Zhang X; Yu H; Lou JR; Zheng J; Zhu H; Popescu NI; Lupu F; Lind SE; Ding WQ
J Biol Chem; 2011 Jan; 286(2):1429-35. PubMed ID: 21059650
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
[TBL] [Abstract][Full Text] [Related]
17. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
18. miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.
Ye Z; Zhao L; Li J; Chen W; Li X
Int J Gynecol Cancer; 2015 Nov; 25(9):1574-81. PubMed ID: 26501435
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
[TBL] [Abstract][Full Text] [Related]
20. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.
Bonnomet A; Syne L; Brysse A; Feyereisen E; Thompson EW; Noël A; Foidart JM; Birembaut P; Polette M; Gilles C
Oncogene; 2012 Aug; 31(33):3741-53. PubMed ID: 22120722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
